Astera Labs director proposes $2.64M share sale
The notice allocates the proposed shares among a trust, an individual retirement account and a limited partnership.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Astera Labs, Inc. (ALAB) director Stefan A. Dyckerhoff filed notice of a proposed sale of 12,499 common shares, with an aggregate market value of $2,642,413.50 and an approximate sale date of November 5, 2026. The notice lists December 1, 2025, as the date of adoption or instruction for a Rule 10b5-1 plan. It attributes the shares among a trust of which Dyckerhoff is trustee (8,333 shares), his individual retirement account (3,505 shares), and a limited partnership of which his trust is general partner (661 shares). The notice also lists two prior sales of 12,499 shares each: on October 7, 2026, for gross proceeds of $4,700,373.00, and on September 2, 2026, for gross proceeds of $3,436,755.00.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Pro-rata distribution from a Venture Fund financial
Private Placement financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.